Profile | GDS4284 / 34846_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 526.326 | 65 |
GSM687648 | Patient 402 control | 545.589 | 65 |
GSM687653 | Patient 403 control | 592.339 | 67 |
GSM687658 | Patient 404 control | 495.63 | 64 |
GSM687663 | Patient 411 control | 653.414 | 67 |
GSM687668 | Patient 422 control | 536.972 | 65 |
GSM687673 | Patient 424 control | 704.125 | 68 |
GSM687678 | Patient 425 control | 516.905 | 63 |
GSM687683 | Patient 427 control | 524.244 | 63 |
GSM687688 | Patient 428 control | 591.105 | 66 |
GSM687695 | Patient 441 control | 1463.77 | 81 |
GSM687699 | Patient 443 control | 536.016 | 64 |
GSM687704 | Patient 444 control | 821.404 | 71 |
GSM687707 | Patient 448 control | 730.988 | 70 |
GSM687712 | Patient 449 control | 638.228 | 67 |
GSM687719 | Patient 450 control | 707.578 | 68 |
GSM687724 | Patient 451 control | 764.528 | 70 |
GSM687728 | Patient 452 control | 665.87 | 68 |
GSM687646 | Patient 401 treated 24h | 590.618 | 65 |
GSM687649 | Patient 402 treated 24h | 609.471 | 66 |
GSM687665 | Patient 411 treated 24h | 504.585 | 63 |
GSM687651 | Patient 402 treated 4 weeks | 744.785 | 69 |
GSM687667 | Patient 411 treated 4 weeks | 730.438 | 69 |
GSM687670 | Patient 422 treated 24h | 575.912 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 545.447 | 65 |
GSM687654 | Patient 403 treated 24h | 615.42 | 67 |
GSM687675 | Patient 424 treated 24h | 765.321 | 70 |
GSM687685 | Patient 427 treated 24h | 610.297 | 66 |
GSM687656 | Patient 403 treated 4 weeks | 638.971 | 68 |
GSM687677 | Patient 424 treated 4 weeks | 608.304 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 447.624 | 62 |
GSM687692 | Patient 428 treated 4h | 444.381 | 62 |
GSM687716 | Patient 449 treated 4h | 420.664 | 62 |
GSM687722 | Patient 450 treated 4h | 655.289 | 67 |
GSM687680 | Patient 425 treated 24h | 663.4 | 68 |
GSM687690 | Patient 428 treated 24h | 514.32 | 65 |
GSM687700 | Patient 443 treated 24h | 898.166 | 71 |
GSM687705 | Patient 444 treated 24h | 479.412 | 64 |
GSM687714 | Patient 449 treated 24h | 497.353 | 64 |
GSM687721 | Patient 450 treated 24h | 1030.65 | 75 |
GSM687682 | Patient 425 treated 4 weeks | 484.658 | 64 |
GSM687694 | Patient 428 treated 4 weeks | 434.951 | 62 |
GSM687702 | Patient 443 treated 4 weeks | 695.766 | 68 |
GSM687718 | Patient 449 treated 4 weeks | 631.216 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 681.149 | 68 |
GSM687661 | Patient 404 treated 4h | 568.062 | 65 |
GSM687710 | Patient 448 treated 4h | 764.842 | 71 |
GSM687726 | Patient 451 treated 4h | 778.302 | 70 |
GSM687730 | Patient 452 treated 4h | 1289.67 | 79 |
GSM687660 | Patient 404 treated 24h | 859.01 | 74 |
GSM687697 | Patient 441 treated 24h | 1168.31 | 77 |
GSM687709 | Patient 448 treated 24h | 543.859 | 65 |
GSM687725 | Patient 451 treated 24h | 914.869 | 73 |
GSM687729 | Patient 452 treated 24h | 1411.07 | 81 |
GSM687727 | Patient 451 treated 4 weeks | 685.402 | 68 |
GSM687731 | Patient 452 treated 4 weeks | 477.872 | 62 |